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SYNTHESES
Two synthetic protocols have been used, named A and B. Throughout the ESI we use the notation nBPmBPn (BP
meaning bipyridinium) for the molecules labelled n.m.n in the main text.
Scheme 1: Syntethic protocols. [nBP][Y] is the  monoalkylated obtained from the first step in protocol B.
Protocol A: 
i) Synthesis of the central core [BPmBP]Br2  (m= 3,4); ii) synthesis of the viologen dimers halides  [nBPmBPn]X4 (n =10,11,12,16;
m= 3,4 ; X = Br, I); iii) metathesis with lithium bistriflimide to obtain the salt [nBPmBPn](Tf2N)4.
Procedure:
i)  Synthesis of the central cores [BP3BP]Br2 and [BP4BP]Br2: 500 mmol  of dibromoethane or dibromopropane were left to  reflux
for 72 hrs in 40mL of ACN (80 °C) with an excess of bipyridine (ratio 1:10). A yellow precipitate was formed.  The suspension was
cooled at 4 ° C for 1 hr and then filtered with Gooch 4 filter, washed with cold acetone and dried under vacuum in presence of CaCl 2
for at least two weeks.Yield:80%.
iii) Synthesis of the viologen dimer halides nBPmBPn:  1 mole of  [BPmBP]Br2 (m=3,4) was letf to  reflux in 20 mL of ACN (80 °C)
with a large excess (ratio 1:20) of the corresponding haloalkanes: C10H21Br, C11H23I, C12H25I, C16H33Br. After about 1 hr a yellow or
red/orange, (depending on the halide),  solid began to precipitate. After 24 hrs MeOH was added drop-wise until a clear solution was
formed; the solution was then left to react for 72 hrs and finally cooled to room temperature and kept at 4°C for 2 hrs. The precipitate
formed was washed with cold acetone (0°C) and recrystallized with a  7% (v/v) solution of methanol in ACN at 40 °C.Yield:60%.
iv) Metathesis with lithium bistriflimide: 300-500 mg of the viologen dimer halide  salt and an excess of LiTf 2N (stoichiometric ratio
1:5) were dissolved in the minimum amount of methanol and left to react for 3 hrs at room temperature under stirring. The volume of
the solution was reduced under vacuum, removing ca. 1/3 of methanol, and then water was added until a white precipitate was
formed. The suspension was left to react for 2 hrs and cooled at 4 °C. The precipitate was then  filtered and washed several times
with water until tests with a 0.5 M solution of AgNO3 showed the absence of halide ions. The product was then dried under vacuum
in the presence of CaCl2 for at least two weeks.Yield:50%-80%.
S2
[10BP4BP10](Tf2N)4 :1H NMR (MeOD, 500  MHz)  9.23 (d, J = 6.4 Hz, 4H);  9.18 (d, J = 6.4 Hz, 4H);  8.63 (d, J = 6.4  Hz, 4H); 8.60 (d, J = 6.5
Hz, 4H); 4.83 (signal partially overlapped to HDO); 4.72 (t, J = 7.5  Hz, 4H); 2.24 (4H); 2.07 (m, 4H); 1.41 (m. 8H);  1.28 (20H); 0.89 (t, J = 6.9 Hz,
6H); 13C NMR (126 MHz, MeOD) δ  151.72, 151.32, 147.06, 128.57, 128.31, 121.1 (q, 1J(13C,19F) = 321.1 Hz ), 63.38, 62.34, 33.01, 32.54, 30.58,
30.46, 30.38, 30.12, 28.84, 27.17, 23.71, 14.41.Elemental Analysis, C52H66F24N8O16S8 : found C 34.87 %, H 3.52 %, N 6.02 %, S 14.41 % ; calcd C
35.25 %, H 3.76 %,  N 6.32 %, S 14.48 %. ESI-MS: m/z=1490 [10BP4BP10(Tf2N)3]+; m/z=605 [10BP4BP10(Tf2N)2]2+.
[11BP4BP11](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.23 (d, J = 6.9 Hz, 4H);  9.18 (d, J = 6.9 Hz, 4H);  8.62 (d, J = 6.7  Hz, 4H); 8.59 (d, J = 6.7
Hz, 4H); 4.83 (signal partially overlapped to HDO); 4.72 (t, J = 7.5  Hz, 4H); 2.24 (4H); 2.07 (m, 4H); 1.41 (m. 8H);  1.28 (24H); 0.89 (t, J = 7.1 Hz,
6H); 13C NMR (126 MHz, MeOD) δ  151.71, 151.32, 147.05, 128.56, 121.1 (q, 1J(13C,19F) = 321.1 Hz) , 63.38, 62.34, 33.04, 32.53, 30.66, 30.62,
30.45, 30.41, 30.11, 28.83, 27.16, 23.71, 14.41. Elemental Analysis, C54H70F24N8O16S8 : found C 35.69 %, H 3.74 %, N 5.97 %, S 14.37 % ; calcd C
36.04 %, H 3.92 %,  N 6.23 %, S 14.25 %. ESI-MS: m/z=1518 [10BP4BP10(Tf2N)3]+; m/z=605 [10BP4BP10(Tf2N)2]2+.
[16BP3BP16](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.65 (d, J = 6.0 Hz, 8H);  9.09 (d, J = 6.4 Hz, 4H);  9.02 (d, J = 6.3  Hz, 4H); 5.36 (d, J = 7.5
Hz, 4H); 5.13 (t, J = 7.5  Hz, 4H); 2.48 (m, 4H);  1.82 (8H);  1.72-1.68 (42H); 1.29 (t, J = 6.8 Hz, 6H); 13C NMR (126 MHz, MeOD) δ  152.17,
151.21, 147.27, 147.08, 128.73, 128.36, 121.1 (q, 1J(13C,19F) = 321.1 Hz ) , 63.42, 59.60, 33.50, 33.07, 32.55, 30.77, 30.75, 30.72, 30.63, 30.47, 30.13,
27.21, 23.73, 14.43. Elemental Analysis, C63H88F24N8O16S8 : found C 38.87 %, H 4.39 %, N 5.62 %, S 13.27 % ; calcd C 39.29 %, H 4.61 %,  N 5.82
%, S 13.32 %. ESI-MS: m/z=1644 [16BP3BP16(Tf2N)3]+; m/z=682 [16BP3BP16(Tf2N)2]2+.
Protocol B:
i) Synthesis of the monoalkylated halides nBPBr (n=8,10,11,12,14,16) ; ii) synthesis of the viologen, [nBPm]X 2 (X= Br , I; m =
3,4,5,6,7,8);  iii) synthesis of the viologen dimers halides  [nBPmBPn]X4 (n =12, 14, 16; m= 3,4,5,6,7,8 ; X = Br, I); iv) metathesis
with lithium bistriflimide to obtain the salt [nBPmBPn](Tf2N)2.
Procedure:
i) Synthesis of the monoalkylated halide:According to ref.[ M. F. Pepitone, G. G. Jernigan, J. S. Melinger, O. -. Kim Org. Lett., 2007,
9, 801-804], 5 g of 4,4'-bipyridine (32 mmol) were dissolved in 150 mL of ACN with the same stoichiometric amount (32 mmol) of
the corresponding haloalkane. The solution was heated with an oil bath at 80 °C for 24 h. After cooling, the yellow precipitate was
filtered and suspended in 300 mL of hot DMF. The monoalkylated product  dissolved in  the DMF while  the yellow, insoluble
dialkylated  salt  was  separated  by filtration.  Ether  was  then  added  to  the  cooled  solution  to  precipitate  the  white/pale  yellow
monoalkylated salt. Yield 70%. 
ii) Synthesis of the viologen: 500 mg of nBPX (X=Br,I) were allowed to reflux in 40 mL of acetonitrile at 80 °C with the appropriate
amount of dibromoalkane (stoichiometric ratio 1:20) and after almost 1 hour a yellow precipitate was formed; the system was left to
react for 24 hours. The obtained precipitate was filtered, washed with cold acetone and dried under vacuum in presence of CaCl2.
Yield 85-95%.
iii) Synthesis of the viologen dimer halides [nBPmBPn]X (X=Br,I):  0.5 mole of  [nBPmX]X was letf to reflux in 20 mL of ACN (80
°C) with an excess (ratio 1:5) of the corresponding monoalkylated halide nBPX. In some cases, once the sample reached 80 °C, a
light suspension was formed: then methanol was added dropwise until a solution was formed. The solutions were refluxed for 96 hrs
and  then  cool  down  at  room temperature  and  stored  at  4°C  for  2  hrs.  The  precipitates  were  filtered  and  recrystallized  with
acetonitrile/methanol mixture (7%-10% in methanol) and, finally, washed with cold acetone and dried under vacuum in presence of
CaCl2 for two weeks. Yield 50%-70%.
iv) Metathesis with lithium bistriflimide: The procedure was the same as described for Protocol A.Yield 70%-80%
[12BP4BP12](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.23 (d, J = 6.7 Hz, 4H);  9.18 (d, J = 6.7 Hz, 4H);  8.62 (d, J = 6.9  Hz, 4H); 8.59 (d, J = 6.7
Hz, 4H); 4.82 (signal partially overlapped to HDO); 4.72 (t, J = 7.4  Hz, 4H); 2.24 ( 4H); 2.07 (m, 4H); 1.41 (m. 8H); 2.24 ( 8H); 1.28 ( 28H); 0.89 (t,
J = 7.1 Hz, 6H);  13C NMR (126 MHz, MeOD)  151.72, 151.32, 147.06, 128.57, 128.32, 121.1 (q,  1J(13C,19F) = 321.1 Hz), 117.29, 63.38, 62.34,
33.05, 32.54, 30.71, 30.62, 30.46, 30.12, 28.84, 27.17, 23.72, 14.42. Elemental Analysis, C56H74F24N8O16S8 : found C 36.79 %, H 4.20 %, N 6.18 %, S
S3
14.42 % ; calcd C 36.80 %, H 4.08 %,  N 6.13 %, S 14.04 %.ESI-MS: m/z=1546 [12BP4BP12(Tf2N)3]+; m/z=634 [12BP4BP12(Tf2N)2]2+;.m/z=329
[12BP4BP12(Tf2N)]3+.
[12BP5BP12](Tf2N)4 : 1H NMR (MeOD, 400 MHz)  9.24 (d, J = 6.5 Hz, 4H);  9.20 (d, J = 6.5 Hz, 4H);  8.62 (d, J = 6.9  Hz, 4H); 8.59 (d, J = 6.7
Hz, 4H); 4.77 (t, J = 7.4  Hz, 4H ); 4.73 (t, J = 7.4  Hz, 4H); 2.24 ( 4H); 2.07 (m, 4H); 1.41 (m. 8H); 1.28 (28H); 0.89 (t, J = 7.1 Hz, 6H);  13C NMR
(101 MHz, MeOD) δ 151.57, 151.35, 146.98, 128.43, 128.29, 121.1 (q, 1J(13C,19F) = 321.1 Hz), 63.35, 62.84, 33.01, 32.51, 31.76, 30.66, 30.58, 30.41,
30.08, 27.15, 23.68, 14.37. Elemental Analysis, C57H76F24N8O16S8 : found C 36.79 %, H 4.02 %, N 6.06 %, S 14.42 % ; calcd C 37.17 %, H 4.16 %,
N 6.08 %, S 13.93 %. ESI-MS: m/z=1560 [12BP5BP12(Tf2N)3]+; m/z=640 [12BP5BP12(Tf2N)2]2+.
[12BP6BP12](Tf2N)4 : 1H NMR (MeOD, 400 MHz)  9.23 (d, J = 6.0 Hz, 4H);  9.20 (d, J = 6.0 Hz, 4H);  8.61 ( 8H);   4.77 (t, J = 7.9  Hz, 4H ); 4.73
(t, J = 7.8  Hz, 4H); 2.09 (broad, 8H); 1.54 (4H); 1.42 ( 8H); 1.29 (b, 28H); 0.89 (t, J = 6.9  Hz, 6H);  13C NMR (101 MHz, MeOD) δ 151.49, 151.41,
147.02,  128.38,  128.30,  121.1  (q,  1J(13C,19F) =  321.1  Hz),  63.38,  63.20,  33.05,  32.55,  32.10,  30.70,  30.62,  30.46,  30.12,  27.19,  26.52,  23.71,
14.41.Elemental Analysis, C58H78F24N8O16S8 : found C 37.31 %, H 4.42 %, N 5.95 %, S 13.92 % ; calcd C 37.54 %, H 4.24 %,  N 6.04 %, S 13.82 %. 
[12BP7BP12](Tf2N)4 :   1H NMR (MeOD, 500  MHz)  9.22 (d, J = 6.8 Hz, 4H);  9.19 (d, J = 6.8 Hz, 4H);  8.64 (d, J = 6.7  Hz, 4H);  8.62 (d, J =
6.9  Hz, 4H);4.77 (t, J = 7.4  Hz, 4H); 4.73 (t, J = 7.4 Hz, 4H); 2.2 (m, 4H);  2.09 (m, 4H); 1.61 (m, 2H); 1.42 (m, 4H); 1.29 (32H); 0.89 (t, J =6.9 Hz,
6H); 13C NMR (126 MHz, MeOD) δ 151.43, 146.97, 128.34, 121.1 (q, 1J(13C,19F) = 321.1 Hz), 63.35, 33.06, 32.56, 32.23, 30.71, 30.63, 30.46, 30.12,
29.55, 27.19, 26.72, 23.72, 14.42. Elemental Analysis, C59H80F24N8O16S8 : found C 37.66 %, H 4.35 %, N 6.09 %, S 13.75 % ; calcd C 37.90 %, H
4.31 %,  N 5.99 %, S 13.72 %. ESI-MS: m/z=1588 [12BP7BP12(Tf2N)3]+; m/z=654 [12BP7BP12(Tf2N)2]2+; m/z=325 [12BP7BP12(Tf2N)]3+
[12BP8BP12](Tf2N)4 :   1H NMR (MeOD, 500  MHz)   9.22 (d, J = 6.8 Hz, 4H);  9.19 (d, J = 6.8 Hz, 4H);  8.60 (d, J = 6.7  Hz, 8H);  4.73 (t, J = 7.4
Hz, 4H); 4.72 (t, J = 7.8 Hz, 4H); 2.09 (broad, 8H);  1.45 (m. 8H); 1.42 ( 8H); 1.32-1.29 ( 28H); 0.89 (t, J =6.9 Hz, 6H); 13C NMR (126 MHz, MeOD)
δ   151.41, 146.97, 128.32,  121.1  (q,  1J(13C,19F) = 321.1 Hz ) , 63.36, 33.04, 32.54, 32.37, 30.70, 30.61, 30.45, 30.11, 29.64, 27.18, 26.88, 23.71,
14.42. Elemental Analysis, C60H82F24N8O16S8 : found C 38.31 %, H 4.29 %, N 5.88 %, S 14.24 % ; calcd C 38.25 %, H 4.39 %,  N 5.95 %, S 13.62 %.
[14BP3BP14](Tf2N)4 : 1H NMR (MeOD, 500 MHz)  9.35 (d, J = 6.8 Hz, 4H); 9.2 (d, J = 6.8 Hz, 4H); 8.71 (d, J = 6.8 Hz, 4H); 8.66 (d, J = 6.6 Hz,
4H); 5.01(t, J = 7.7 Hz, 4H); 4.74 (d, J = 7.6 Hz, 4H); 2.95 (m, 2H); 2.09 (m, 4H);1.42 ( 8H); 1.32-1.28 (36H);  0.89 (t, J =6.9 Hz, 6H); 13C NMR
(MeOD,  126 MHz): δ 152.01, 151.27, 147.37, 147.08, 128.69, 128.37, 121.1 (q, 1J(13C,19F) = 321.1 Hz ), 63.39, 59.53, 33.53, 33.07, 32.57, 30.78,
30.75, 30.72, 30.64, 30.49, 30.46, 30.15, 27.23, 23.73, 14.42. Elemental Analysis, C59H80F24N8O16S8 : found C 38.33 %, H 4.64 %, N 5.75 %, S 13.24
% ; calcd C 37.90 %, H 4.31 %,  N 5.99 %, S 13.72 %. ESI-MS: m/z=1588 [14BP3BP14(Tf2N)3]+; m/z=654 [14BP3BP14(Tf2N)2]2+.
[14BP4BP14](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.24 (d, J = 6.9 Hz, 4H);  9.19 (d, J = 6.9 Hz, 4H);  8.63 (d, J = 6.8  Hz, 8H); 8.60 (d, J = 6.8
Hz, 8H);  4.83 (partially overlapped to HDO); 4.72 (t, J = 7.6 Hz, 4H); 2.24 ( 4H); 2.07 (m, 4H);  1.41 (m. 8H); 1.28 (36H); 0.90 (t, J =7.0 Hz, 6H);
13C NMR (126 MHz, MeOD)  151.72, 151.32, 147.07, 128.57, 128.31, 121.1 (q, 1J(13C,19F) = 321.1 Hz) , 63.38, 62.34, 33.07, 32.55, 30.78, 30.74,
30.72, 30.63, 30.47, 30.13, 28.84, 27.18, 23.73, 14.43. Elemental Analysis, C60H82F24N8O16S8 : found C 38.43 %, H 4.69 %, N 5.90 %, S 13.67 % ;
calcd C 38.25 %, H 4.39 %,  N 5.95 %, S 13.62 %. ESI-MS: m/z=1603 [14BP4BP14(Tf2N)3]+; m/z=662 [14BP3BP14(Tf2N)2]2+.
[14BP5BP14](Tf2N)4 :  1H NMR (MeOD, 400  MHz)    9.24 (d, J = 6.8 Hz, 4H);  9.29 (d, J = 6.8 Hz, 4H);  8.64-8.62 (two doublets partially
overlapped, J = 6.3 HZ; J =n.d.,8H);  4.77 (t, J = 7.6 Hz, 4H);  4.72 (t, J = 7.6 Hz, 4H); 2.20 (m, 4H); 2.08 (m, 4H);  1.60 (b, 2H); 1.42 (8H)1.29
(36H); 0.89 (t, J =7.0 Hz, 6H);  13C NMR (MeOD, 101MHz)  151.60, 151.38, 147.02, 128.46, 128.32, 121.1 (q,  1J(13C,19F) = 321.1 Hz ), 63.38,
62.87, 33.06, 32.57, 31.81, 30.78, 30.63, 30.47, 30.13, 27.20, 23.72, 14.42.
Elemental Analysis, C61H84F24N8O16S8 : found C 39.24 %, H 4.30 %, N 6.02 %, S 13.93 % ; calcd C 38.60 %, H 4.46 %,  N 5.90 %, S 13.52 %. ESI-
MS: m/z=1616.5 [14BP5BP14(Tf2N)3]+; m/z=668.2 [14BP5BP14(Tf2N)2]2+; m/z=352.3 [14BP6BP14(Tf2N)]3+.
[14BP6BP14](Tf2N)4 :  1H NMR (MeOD, 500  MHz)    9.22 (d, J = 6.8 Hz, 4H);  9.19 (d, J = 6.8 Hz, 4H);  8.61- 8.60 (two doublets partially
overlapped, 8H);  4.74 - 4.72 (two triplets partially overlapped, 8H); 2.10 (m, 8H); 1.53 (b, 4H);  1.41 (8H); 1.29 (36H); 0.90 (t, J =7.0 Hz, 6H); 13C
NMR (126 MHz, MeOD)   151.47, 146.99, 128.38, 121.1 (q, 1J(13C,19F) = 321.1 Hz ), 63.36, 63.18, 33.06, 32.55, 32.08, 30.78, 30.74, 30.71, 30.62,
30.46, 30.12, 27.18, 26.48, 23.72, 14.42. Elemental Analysis, C62H86F24N8O16S8 : found C 38.56 %, H 4.43 %, N 5.80 %, S 13.55 % ; calcd C 38.95
%,  H  4.53  %,   N  5.86  %,  S  13.42  %.  ESI-MS:  m/z=1630.5  [14BP6BP14(Tf2N)3]+;  m/z=675.2  [14BP6BP14(Tf2N)2]2+;  m/z=357.0
[14BP6BP14(Tf2N)]3+.
[16BP4BP16](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.24 (d, J = 6.9 Hz, 4H);  9.19 (d, J = 6.9 Hz, 4H);  8.63 (d, J = 6.8  Hz, 8H); 8.60 (d, J = 6.7
Hz, 8H);  4.83 (partially overlapped to HDO); 4.72 (t, J = 7.6 Hz, 4H); 2.24  (4H); 2.07 (m, 4H);  1.41 (m. 8H); 1.28 (44H); 0.90 (t, J =7.0 Hz, 6H);
13C NMR (126 MHz, MeOD)   151.72, 151.31, 147.07, 128.57, 128.31, 121.1 (q, 1J(13C,19F) = 321.1 Hz),  63.38, 62.34, 33.07, 32.55, 30.78, 30.75,
30.72, 30.64, 30.47, 30.14, 28.84, 27.19, 23.73, 14.43. Elemental Analysis, C64H90F24N8O16S8 : found C 39.18 %, H 4.71 %, N 5.48 %, S 13.14 % ;
calcd C 39.62 %, H 4.68 %,  N 5.78 %, S 13.22 %. ESI-MS:  m/z=1658 [16BP4BP16(Tf2N)3]+;  m/z=689 [16BP4BP16(Tf2N)2]2+. We also observed
two intense peaks in the ESI-MS spectrum at m/z = 1630 and 675, corresponding to a monocationic and dicationic species, respectively (as inferred
from the spacing of the isotope peaks), that could not be assigned.
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[16BP5BP16](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.24 (d, J = 6.9 Hz, 4H);  9.20 (d, J = 6.8 Hz, 4H);  8.64 (m, J =6.9 Hz, 4H); 8.62 (d, J = 6.8
Hz, 4H);  4.77 (t, J = 7.4 Hz, 4H); 4.73 (t, J = 7.5 Hz, 4H); 2.20 (m, 4H); 2.08 (m, 4H);  1.61 (m, 2H); 1.42 (8H); 1.32 - 1.28 (44H); 0.90 (t, J =6.9Hz,
6H); 13C NMR (126 MHz, MeOD) δ  151.59, 151.37, 147.01, 128.46, 128.32,121.1 (q, 1J(13C,19F) = 321.1 Hz) , 63.38, 62.87, 33.05, 32.55, 31.78,
30.76, 30.73, 30.70, 30.62, 30.45, 30.12, 27.19, 23.71, 14.41: Elemental Analysis, C65H92F24N8O16S8 : found C 38.22 %, H 4.69 %, N 5.25 %, S 12.57
% ; calcd C 39.95 %, H 4.75 %,  N 5.73 %, S 13.13 %. ESI-MS: m/z=1673.8 [16BP5BP16(Tf2N)3]+; m/z=696.8 [16BP5BP16(Tf2N)2]2+; m/z=371.2
[16BP5BP16(Tf2N)]3+.
[16BP6BP16](Tf2N)4 : 1H NMR (MeOD, 500  MHz)  9.22 (d, J = 6.7 Hz, 4H);  9.19 (d, J = 6.7 Hz, 4H);  8.60 (m, 8H); 8.60 (d, J = 6.7  Hz, 8H);
4.74 (t, J = 7.4 Hz, 4H); 4.72 (t, J = 7.5 Hz, 4H); 2.09 (m, 8H); 2.09 (m, 4H);  1.53 (b, 4H); 1.42 (8H); 1.28 ( 32H); 0.90 (t, J =6.9Hz, 6H); 13C NMR
(126 MHz, MeOD) δ   151.47, 151.39, 146.99, 128.38, 128.30,121.1  (q,  1J(13C,19F) = 321.1 Hz) , 63.36, 63.19, 33.07, 32.55, 32.08, 30.78, 30.75,
30.71, 30.12, 27.18, 26.48, 23.73, 14.43: Elemental Analysis, C66H94F24N8O16S8 : found C 38.19 %, H 4.74 %, N 5.13 %, S 12.70 % ; calcd C 40.28
%, H 4.81 %,  N 5.69 %, S 13.03 %. ESI-MS: m/z=1686 [16BP6BP16(Tf2N)3]+; m/z=703 [16BP6BP16(Tf2N)2]2+; m/z=375 [16BP6BP16(Tf2N)]3+.
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Fig S1: 1H NMR (MeOD, 500  MHz) of [10BP4BP10](Tf2N)4 
Fig S2: 1H NMR (MeOD, 500  MHz) of [11BP4BP11](Tf2N)4 
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Fig S3: 1H NMR (MeOD, 500  MHz) of [16BP3BP16](Tf2N)4 
Fig S4: 1H NMR (MeOD, 500  MHz) of [12BP4BP12](Tf2N)4 
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Fig S5: 1H NMR (MeOD, 400  MHz) of [12BP5BP12](Tf2N)4 
Fig S6: 1H NMR (MeOD, 400  MHz) of [12BP6BP12](Tf2N)4 
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Fig S7: 1H NMR (MeOD, 500  MHz) of [12BP7BP12](Tf2N)4 
Fig S8: 1H NMR (MeOD, 500  MHz) of [12BP8BP12](Tf2N)4 
S9
Fig S9: 1H NMR (MeOD, 500  MHz) of [14BP3BP14](Tf2N)4 
Fig S10: 1H NMR (MeOD, 500  MHz) of [14BP4BP14](Tf2N)4 
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Fig S11: 1H NMR (MeOD, 400  MHz) of [14BP5BP14](Tf2N)4 
Fig S12: 1H NMR (MeOD, 500  MHz) of [14BP6BP14](Tf2N)4 
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Fig S13: 1H NMR (MeOD, 500  MHz) of [16BP4BP16](Tf2N)4 
Fig S14: 1H NMR (MeOD, 500  MHz) of [16BP5BP16](Tf2N)4 
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Fig S15: 1H NMR (MeOD, 500  MHz) of [16BP6BP16](Tf2N)4 
Fig S16: 13C NMR (MeOD, 126  MHz) of [10BP4BP10](Tf2N)4 
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Fig S17: 13C NMR (MeOD, 126  MHz) of [11BP4BP11](Tf2N)4 
Fig S18: 13C NMR (MeOD, 126  MHz) of [16BP3BP16](Tf2N)4
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Fig S19: 13C NMR (MeOD, 126  MHz) of [12BP4BP12](Tf2N)4
Fig S20: 13C NMR (MeOD, 101  MHz) of [12BP5BP12](Tf2N)4
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Fig S21: 13C NMR (MeOD, 101  MHz) of [12BP6BP12](Tf2N)4
Fig S22: 13C NMR (MeOD, 126  MHz) of [12BP7BP12](Tf2N)4
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Fig S23: 13C NMR (MeOD, 126  MHz) of [12BP8BP12](Tf2N)4
Fig S24: 13C NMR (MeOD, 126  MHz) of [14BP3BP14](Tf2N)4
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Fig S25: 13C NMR (MeOD, 126  MHz) of [14BP4BP14](Tf2N)4
Fig S26: 13C NMR (MeOD, 126  MHz) of [14BP5BP14](Tf2N)4
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Fig S27: 13C NMR (MeOD, 126  MHz) of [14BP6BP14](Tf2N)4
Fig S28: 13C NMR (MeOD, 126  MHz) of [16BP4BP16](Tf2N)4
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Fig S29: 13C NMR (MeOD, 126  MHz) of [16BP5BP16](Tf2N)4
Fig S30: 13C NMR (MeOD, 126  MHz) of [16BP6BP16](Tf2N)4
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Fig S31:Textures of the SmX phase on cooling from the melt of: a) 8.8.8 at 145 °C; b) 10.4.10 at 130 °C; 12.6.12 at
170 °C observed under crossed-polarizers.
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Figure S32: (Left panels) XRD patterns of samples a) 16.3.16, b) 16.4.16 c) 16.5.16 d) 16.6.16, acquired at the 
indicated temperatures. 
(Right panels) Zoom of the low-angle region of the XRD patterns of samples a) 16.3.16, b) 16.4.16 c) 16.5.16 d) 
16.6.16, acquired at the indicated temperatures. Note that the y scale hase been arbitrarily rescaled to fit the 
trace.
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Fig S33: 13C variable temperature (°C) MAS NMR (100  MHz, 5 kHz MAS) of [16BP4BP16](Tf2N)4
Fig S34: 13C variable temperature (°C) MAS NMR (100  MHz, 5 kHz MAS) of [16BP3BP16](Tf2N)4
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Fig S35: 19F variable temperature (°C) MAS NMR (376  MHz, 10 kHz MAS) of [16BP6BP16](Tf2N)4
Fig S36: 19F variable temperature (°C) MAS NMR (376  MHz, 10 kHz MAS) of [16BP5BP16](Tf2N)4
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Fig S37: TOCSY (500.13 MHz) of [16BP5BP16](Tf2N)4. 
Fig  S38:1H-13C HSQC (500.13; 125.77 MHz) of [16BP5BP16](Tf2N)4.
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